scispace - formally typeset
L

Leon Harisiadis

Researcher at Columbia University

Publications -  5
Citations -  501

Leon Harisiadis is an academic researcher from Columbia University. The author has contributed to research in topics: Germinoma & Sister chromatid exchange. The author has an hindex of 5, co-authored 5 publications receiving 499 citations.

Papers
More filters
Journal ArticleDOI

Midline pineal tumors and suprasellar germinomas: highly curable by irradiation.

TL;DR: Sixty-one patients with midline pineal tumors and 16 patients with suprasellar germinomas were treated with surgical decompression and relatively high-dose radiotherapy of the primary site, and there were no long-term complications.
Journal ArticleDOI

A vitamin A analogue inhibits radiation-induced oncogenic transformation

TL;DR: It is investigated here the possibility that retinoids might also inhibit radiation-induced oncogenic transformation using a cell line of C3H mouse embryo fibroblasts grown in culture, and a marked reduction in the transformation frequency is reported.
Journal ArticleDOI

Thermal tolerance and repair of thermal damage by cultured cells.

TL;DR: Prolonged exposure to 42.5 degrees C for long periods offers considerable protection from subsequent treatments to acute hyperthermia at 45 degrees C indicate or in conditioned medium or balanced salt solution failed to reveal any evidence of repair of potentially lethal damage.
Journal ArticleDOI

Hyperthermia and low dose-rate irradiation.

TL;DR: Maximal enhancement was observed when hyperthermia was followed by irradiations, and the probable explanation is that, by damaging the repair system, prior heat renders the cells unable to repair sublethal damage during subsequent low dose-rate irradiation.
Journal Article

Modification of Sister Chromatid Exchanges and Radiation-induced Transformation in Rodent Cells by the Tumor Promoter 12-O-Tetradecanoylphorbol-13-acetate and Two Retinoids

TL;DR: Results indicate that, while sister chromatid exchanges may be useful as indicators of primary carcinogen mutagens, they may have little utility when secondary agents after the response of cells to a primary initiator.